评估处方者遵守全球喘倡议 (GINA) 指南建议的缓解疗法
Stephanie Tchen1, Truong Vu2, Megan Fleischman3
1Department of Pharmacy, Froedtert Hospital, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
Internal and emergency medicine
|September 11, 2023
概括
该研究发现,虽然遵守全球喘倡议 (GINA) 关于喘缓解治疗的指导方针在住院后有所改善,但只有2.4%的患者接受了首选的吸入性皮质类固醇 (ICS) - 形式醇治疗. 需要进一步的研究来了解粘附障碍.
科学领域:
- 肺部病理学 肺部病理学
- 临床实践指南 临床实践指南
- 药物治疗 药物治疗
背景情况:
- 2019年全球喘倡议 (GINA) 的指导方针建议根据需要使用低剂量的吸入性皮质类固醇 (ICS) - 甲醇作为所有喘患者首选的缓解疗法.
- 短效β-激动剂 (SABA) 单疗不再建议用于喘缓解.
研究的目的:
- 评估医疗保健提供者是否遵守关于喘缓解剂治疗的GINA指南.
- 在喘恶化管理中,量化首选缓解疗法 (ICS-formoterol) 与替代疗法 (SABA) 的采用情况.
主要方法:
- 一项回顾性队列研究分析了127名2020年至2021年1月至5月期间急性喘恶化患者.
- 根据医院出院时的处方缓解剂治疗来评估提供者坚持.
- 二级目标包括皮质类固醇的使用和潜在的候选人优先缓解疗法.
主要成果:
- 在出院后,只有2.4%的患者接受了首选的ICS-formoterol缓解疗法,而76.4%的人接受了替代SABA治疗.
- 推的缓解疗法处方率显著增加,从住院后的55%增加到79% (p < 0.001).
结论:
- 在住院治疗后,喘缓解疗法的遵守GINA指南显著改善,但首选的ICS-formoterol方法仍未得到充分利用.
- 需要进一步调查防止广泛采用首选的GINA缓解疗法的障碍.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:23Inhaled Medications
305
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
305
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
295
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
295
01:17Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481
01:26COPD: Management Using Bronchodilators and Corticosteroids
241
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
241